Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 9/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | NQO2 | P16083 | 1/20 | 0.38 |
| ▸ | MTNR1B | P49286 | 6/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7690978 | 1.00 | MTNR1A (0.41) | MTNR1AKDM4EALDH1A1GAANQO2 | |
| SCHEMBL27695213 | 0.98 | MTNR1A (0.40) | MTNR1AKDM4EALDH1A1GAANQO2 | |
| SCHEMBL7692450 | 0.98 | MTNR1A (0.42) | MTNR1AKDM4EALDH1A1GAANQO2 | |
| SCHEMBL7691848 | 0.95 | MTNR1A (0.42) | MTNR1AKDM4EALDH1A1GAANQO2 | |
| SCHEMBL1567131 | 0.87 | ALDH1A1 (0.43) | MTNR1AKDM4EALDH1A1GAANQO2 | |
| SCHEMBL7643869 | 0.85 | MTNR1A (0.47) | MTNR1ANQO2GPR84SLC16A3 | |
| SCHEMBL129449 | 0.85 | MTNR1A (0.47) | MTNR1ANQO2GPR84SLC16A3 | |
| SCHEMBL12981740 | 0.85 | MTNR1A (0.47) | MTNR1ANQO2GPR84SLC16A3 | |
| SCHEMBL128593 | 0.85 | MTNR1A (0.47) | MTNR1ANQO2GPR84SLC16A3 | |
| SCHEMBL12982184 | 0.85 | MTNR1A (0.47) | MTNR1ANQO2GPR84SLC16A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002000622-A2 | AMINOALCOHOL DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-01-03 | — | — | WO | disclosed |